ArticleJournal of diabetes and metabolic disorders2025
Evaluation of hearing function in patients with type 2 diabetes mellitus and investigation of its relationship with stages of diabetic retinopathy.
Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hearing Health Monitoring in Adults Living with Diabetes: A Scoping Review to Inform Integrated Care Pathways.Audiology research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetes mellitus is a serious, chronic metabolic disorder associated with microvascular and macrovascular complications that affect the cardiac, renal, ophthalmic, cerebral, and peripheral systems. Similar complications can also occur in the structures of the inner ear. Objectives: This study aimed to assess the hearing function of patients diagnosed with T2DM and to investigate the relationship between hearing function and the stage of diabetic retinopathy. Methods: This prospective, single-center, cross-sectional, and case-control study included 30 healthy controls (Group 1) and 90 patients with T2DM [30 without retinopathy (Group 2), 30 with non-proliferative diabetic retinopathy (Group 3), and 30 with proliferative diabetic retinopathy (Group 4)] aged 40 to 60 years. The best-corrected visual acuity and audiological tests, including pure tone audiometry (PTA) and high frequency audiometry (HFA), were performed. Results: A statistically significant difference was observed at all frequencies (for all, Conclusions: It was observed that T2DM patients were at risk for developing hearing impairment, and sensorineural hearing impairment increased as the DR stage progressed, particularly in high frequencies. These results suggest a hearing evaluation in the screening of DR patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.